Clinical Trials
3 trialsNCT04481204 2026-05-04
New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT07240766 2026-02-13
HRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D Mutation
Zhejiang University
Phase 2 Recruiting
NCT07080021 2025-07-29
MRD
Ruijin Hospital
Recruiting